Yaghjyan Lusine, Colditz Graham A, Rosner Bernard, Tamimi Rulla M
Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, USA.
Breast Cancer Res Treat. 2015 Feb;150(1):181-9. doi: 10.1007/s10549-015-3286-6. Epub 2015 Feb 13.
We investigated if associations of breast density and breast cancer differ according to the level of other known breast cancer risk factors, including body mass index (BMI), age at menarche, parity, age at first child's birth, age at menopause, alcohol consumption, a family history of breast cancer, a history of benign breast disease, and physical activity. This study included 1,044 postmenopausal incident breast cancer cases diagnosed within the Nurses' Health Study cohort and 1,794 matched controls. Percent breast density, absolute dense, and non-dense areas were measured from digitized film images with computerized techniques. Information on breast cancer risk factors was obtained prospectively from biennial questionnaires. Percent breast density was more strongly associated with breast cancer risk in current postmenopausal hormone users (≥50 vs. 10 %: OR 5.34, 95 % CI 3.36-8.49) as compared to women with past (OR 2.69, 95 % CI 1.32-5.49) or no hormone history (OR 2.57, 95 % CI 1.18-5.60, p-interaction = 0.03). Non-dense area was inversely associated with breast cancer risk in parous women, but not in women without children (p-interaction = 0.03). Associations of density with breast cancer risk did not differ by the levels of BMI, age at menarche, parity, age at first child's birth, age at menopause, alcohol consumption, a family history of breast cancer, a history of benign breast disease, and physical activity. Women with dense breasts, who currently use menopausal hormone therapy are at a particularly high risk of breast cancer. Most breast cancer risk factors do not modify the association between mammographic breast density and breast cancer risk.
我们研究了乳腺密度与乳腺癌之间的关联是否会因其他已知乳腺癌风险因素的水平不同而有所差异,这些因素包括体重指数(BMI)、初潮年龄、生育情况、首次生育年龄、绝经年龄、饮酒量、乳腺癌家族史、良性乳腺疾病史以及身体活动情况。本研究纳入了护士健康研究队列中确诊的1044例绝经后新发乳腺癌病例以及1794例匹配对照。采用计算机技术从数字化胶片图像测量乳腺密度百分比、绝对致密区和非致密区。乳腺癌风险因素信息通过每两年一次的问卷调查前瞻性获取。与既往使用过激素(比值比[OR]2.69,95%置信区间[CI]1.32 - 5.49)或无激素使用史的女性(OR 2.57,95%CI 1.18 - 5.60,P交互作用 = 0.03)相比,目前使用绝经后激素的女性中,乳腺密度百分比与乳腺癌风险的关联更强(≥50% vs. 10%:OR 5.34,95%CI 3.36 - 8.49)。在有子女的女性中,非致密区与乳腺癌风险呈负相关,但在无子女的女性中并非如此(P交互作用 = 0.03)。密度与乳腺癌风险的关联在BMI、初潮年龄、生育情况、首次生育年龄、绝经年龄、饮酒量、乳腺癌家族史、良性乳腺疾病史以及身体活动情况的不同水平之间并无差异。目前使用绝经激素治疗的乳腺致密女性患乳腺癌的风险特别高。大多数乳腺癌风险因素并不会改变乳腺钼靶密度与乳腺癌风险之间的关联。